The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhananjay Ashokkumar Barot, a member of the promoter group of Senores Pharmaceuticals, sold 5,111 equity shares in the open market on August 20, 2025. This disposal brought his holding down from 317,800 shares (0.69%) to 312,689 shares (0.68%) of the company's equity capital. The total share capital of the company remains unchanged at 46,053,588 shares. The transaction was carried out on both BSE (scrip code 544319) and NSE (symbol: SENORES).
This is a very small sale (just 0.01% of share capital) by an individual promoter and is unlikely to have any meaningful impact on the stock price or overall promoter holding pattern. Retail investors need not be concerned as the promoter remains invested in the company.